What question did this study set out to answer?

To evaluate the impact of immunotherapy on advanced cutaneous squamous cell carcinoma (CSCC).

SRS312 - Role of immunotherapy in advanced cutaneous squamous skin caner

View Full Paper

Ask AI

Bookmark

Authors

Case Reports Demonstrate Immunotherapy's Efficacy in Advanced Cutaneous Squamous Cell Carcinoma, Suggesting a Promising Treatment Strategy.

To evaluate the impact of immunotherapy on advanced cutaneous squamous cell carcinoma (CSCC).
Reviewed three cases of advanced CSCC treated with immunotherapy.
Assessed clinical and radiological regression outcomes post-treatment.
Conducted a literature review on immunotherapy efficacy and safety.
Over 60% of patients achieved complete remission with PD-1 inhibitors.
Clinical regression observed in all presented cases after immunotherapy.
Current literature indicates promising results but highlights management challenges for advanced CSCC.

Kaur et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Case Reports Demonstrate Immunotherapy's Efficacy in Advanced Cutaneous Squamous Cell Carcinoma, Suggesting a Promising Treatment Strategy.